ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, featuring promising advancements throughout several medical and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA gives a safer, much more reputable substitute for therapeutic use, p